1
|
Patel T: Increasing incidence and
mortality of primary intrahepatic cholangiocarcinoma in the United
States. Hepatology. 33:1353–1357. 2001. View Article : Google Scholar : PubMed/NCBI
|
2
|
Gores GJ: Cholangiocarcinoma: Current
concepts and insights. Hepatology. 37:961–969. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wu L, Li X, Ye L, et al: Vascular
endothelial growth inhibitor is a negative regulator of
aggressiveness and microvascular density in human clear cell renal
cell carcinoma. Anticancer Res. 34:715–722. 2014.PubMed/NCBI
|
4
|
Lozano-Santos C, Martinez-Velasquez J,
Fernandez-Cuevas B, et al: Vascular endothelial growth factor A
(VEGFA) gene polymorphisms have an impact on survival in a subgroup
of indolent patients with chronic lymphocytic leukemia. PLoS One.
27:e1010632014. View Article : Google Scholar
|
5
|
Zhao R, Liu XQ, Wu XP, et al: Vascular
endothelial growth factor (VEGF) enhances gastric carcinoma
invasiveness via integrin alpha(v)beta6. Cancer Lett. 287:150–156.
2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Skobe M, Hamberg LM, Hawighorst T, et al:
Concurrent induction of lymphangiogenesis, angiogenesis and
macrophage recruitment by vascular endothelial growth factor-C in
melanoma. Am J Pathol. 159:893–903. 2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Decio A, Taraboletti G, Patton V, et al:
Vascular endothelial growth factor c promotes ovarian carcinoma
progression through paracrine and autocrine mechanisms. Am J
Pathol. 184:1050–1061. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Liu J, Liu C, Qiu L, Li J, Zhang P and Sun
Y: Overexpression of both platelet-derived growth factor-BB and
vascular endothelial growth factor-C and its association with
lymphangiogenesis in primary human non-small cell lung cancer.
Diagn Pathol. 9:1282014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Ciobanu M, Eremia IA, Crăiţoiu S, et al:
Lymphatic microvessels density, VEGF-C and VEGFR-3 expression in 25
cases of breast invasive lobular carcinoma. Rom J Morphol Embryol.
54:925–934. 2013.PubMed/NCBI
|
10
|
Ishikawa M, Kitayama J, Kazama S and
Nagawa H: Expression of vascular endothelial growth factor C and D
(VEGF-C and -D) is an important risk factor for lymphatic
metastasis in undifferentiated early gastric carcinoma. Jpn J Clin
Oncol. 33:21–27. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Yonemura Y, Endo Y, Fujita H, et al: Role
of vascular endothelial growth factor C expression in the
development of lymph node metastasis in gastric cancer. Clin Cancer
Res. 5:1823–1829. 1999.PubMed/NCBI
|
12
|
Kono M, Watanabe M, Abukawa H, Hasegawa O,
Satomi T and Chikazu D: Cyclo-oxygenase-2 expression is associated
with vascular endothelial growth factor C expression and lymph node
metastasis in oral squamous cell carcinoma. J Oral Maxillofac Surg.
71:1694–1702. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Rubbia-Brandt L, Terris B, Giostra E,
Dousset B, Morel P and Pepper MS: Lymphatic vessel density and
vascular endothelial growth factor-C expression correlate with
malignant behavior in human pancreatic endocrine tumors. Clin
Cancer Res. 10:6919–6928. 2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Aishima S, Nishihara Y, Iguchi T, Taguchi
K, Taketomi A, Maehara Y and Tsuneyoshi M: Lymphatic spread is
related to VEGF-C expression and D2-40-positive myofibroblasts in
intrahepatic cholangiocarcinoma. Mod Pathol. 21:256–264. 2008.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Wang WB, Li YH, Liu B, Wang HS, Cui AR and
Zhnag XH: Correlation between PPARgamma and VEGF-C expression in
extrahepatic cholangioadenocarcinoma (EHCAC) and their prognostic
significance. Zhonghua Zhong Liu Za Zhi. 31:773–777. 2009.(In
Chinese). PubMed/NCBI
|